CONMED Corporation (CNMD) — Financial statements
Income statement, balance sheet, and cash flow for CONMED Corporation — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,374↑5.2% | 1,307↑5.0% | 1,245↑19.1% | 1,045↑3.4% | 1,011 | |
| Cost of Revenue | 649↑13.1% | 574↑1.0% | 568↑19.9% | 474↑7.1% | 443 | |
| Gross Profit | 725↓1.0% | 733↑8.4% | 676↑18.4% | 571↑0.6% | 568 | |
| Operating Expenses | ||||||
| R&D Expenses | 56↑2.7% | 54↑3.5% | 53↑11.6% | 47↑8.2% | 44 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 528↑10.5% | 478↓4.9% | 503↑10.8% | 454↑9.5% | 415 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 584↑9.7% | 533↓4.1% | 556↑10.9% | 501↑9.4% | 458 | |
| Total Costs & Expenses | 1,233↑11.4% | 1,107↓1.6% | 1,124↑15.2% | 975↑8.3% | 901 | |
| Operating Results | ||||||
| Operating Income | 141↓29.5% | 200↑66.1% | 121↑72.2% | 70↓36.2% | 110 | |
| Depreciation & Amortization | 52↓27.2% | 72↓0.0% | 72↑44.5% | 50↓29.7% | 71 | |
| EBITDA | 193↓28.9% | 272↑41.4% | 192↑2368.3% | 8↓95.7% | 179 | |
| EBIT | 141↓29.5% | 200↑66.1% | 121↑387.4% | -42↓138.6% | 109 | |
| Interest & Other Income | ||||||
| Net Interest Income | -31↑16.7% | -37↑6.2% | -40↓37.6% | -29↑18.5% | -35 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 31↓16.7% | 37↓6.2% | 40↑37.6% | 29↓18.5% | 35 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00↓100.0% | 112↑9838.9% | 1 | |
| Other Income / Expenses | -70↓87.7% | -37↑6.2% | -40↑71.8% | -141↓284.9% | -37 | |
| Income Before Tax | 71↓56.4% | 163↑101.7% | 81↑214.1% | -71↓196.9% | 73 | |
| Income Tax Expense | 24↓21.4% | 31↑87.0% | 16↑68.4% | 10↓8.0% | 11 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 47↓64.5% | 132↑105.4% | 64↑180.0% | -81↓228.8% | 63 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 47↓64.5% | 132↑105.4% | 64↑180.0% | -81↓228.8% | 63 | |
| Bottom-Line Net Income | 47↓64.5% | 132↑105.4% | 64↑180.0% | -81↓228.8% | 63 | |
| EPS (Basic) | 1.52↓64.6% | 4.29↑104.3% | 2.10↑178.4% | -2.68↓225.2% | 2.14 | |
| EPS (Diluted) | 1.51↓64.6% | 4.26↑108.8% | 2.04↑176.1% | -2.68↓238.1% | 1.94 | |
| Weighted Average Shares | 31↑0.6% | 31↑0.6% | 31↑2.1% | 30↑3.0% | 29 | |
| Weighted Average Diluted Shares | 31↑0.1% | 31↓1.4% | 32↑5.0% | 30↓6.8% | 32 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.